Commentary

Video

Gene and Cell Therapy: Shaping the Future of Medicine

Author(s):

Marco Davila, MD, PhD

Marco Davila, MD, PhD, discusses how to shape the future of medicine with gene and cell therapy.

Marco Davila, MD, PhD, discusses how to shape the future of medicine with gene and cell therapy.

Related Videos
Renier Brentjens, MD, PhD,
Marco Davila, MD, PhD
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Estelamari Rodriguez, MD
Tom van Meerten, MD, PhD, hematologist, Department of Hematology, University Medical Center Groningen
Andrew Ip, MD
Eunice S. Wang, MD
Marcella Ali Kaddoura, MD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the multidisciplinary management of NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Related Content
Colorectal Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
January 25th 2025

Encorafenib/Cetuximab Plus Chemo Drives ORR Improvement in BRAF V600E+ mCRC

Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD
October 30th 2024

Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD

Maurie Markman, MD
January 23rd 2025

Unique Questions Associated With the Increasing Prominence of Precision/Genomic Medicine in Routine Cancer Care

Brentjens on the Next Chapter of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
October 10th 2022

Brentjens on the Next Chapter of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

The FDA approved sotorasib (Lumakras) with panitumumab (Vectibix) for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer, as determined by an FDA-approved test, who have previously received fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
January 16th 2025

FDA Approves Sotorasib Plus Panitumumab for KRAS G12C–Mutated Colorectal Cancer

FDA
January 16th 2025

Lete-Cel Receives FDA Breakthrough Therapy Designation for Advanced Myxoid/Round Cell Liposarcoma